seed
Stage
1
Investors
About
Rational Vaccines is a biotechnology company developing vaccines, therapeutics and diagnostics targeting herpes simplex virus (HSV-1 and HSV-2). Their platform advances rationally designed attenuated live viruses engineered to avoid neuronal latency for both prophylactic and therapeutic applications.
Explore Rational Vaccines's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.